Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
M12.DE Stock Summary
Top 10 Correlated ETFs
M12.DE
In the News
M12.DE Financial details
Company Rating
Strong Buy
Market Cap
239.75M
Income
13.23M
Revenue
585.82M
Book val./share
5.38
Cash/share
2.69
Dividend
-
Dividend %
-
Employees
366
Optionable
No
Shortable
Yes
Earnings
18 Apr 2024
P/E
30.56
Forward P/E
19.55
PEG
6.01
P/S
0.71
P/B
2.31
P/C
4.87
P/FCF
10.61
Quick Ratio
1.38
Current Ratio
2.86
Debt / Equity
0.07
LT Debt / Equity
0.02
-
-
EPS (TTM)
0.72
EPS next Y
0.67
EPS next Q
-
EPS this Y
-50%
EPS next Y
-7.48%
EPS next 5Y
36.7%
EPS last 5Y
-9.25%
Revenue last 5Y
34.34%
Revenue Q/Q
2.84%
EPS Q/Q
18.75%
-
-
-
-
SMA20
-
SMA50
18.18%
SMA100
44.44%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.06%
Gross Margin
19%
Oper. Margin
3%
Profit Margin
2%
Payout
26%
Shs Outstand
18.23M
Shs Float
5.7M
-
-
-
-
Target Price
-
52W Range
5.84-14.95
52W High
-6.43%
52W Low
+162%
RSI
49
Rel Volume
0.68
Avg Volume
17.84K
Volume
12.04K
Perf Week
1.55%
Perf Month
16.44%
Perf Quarter
50.57%
Perf Half Y
36.74%
-
-
-
-
Beta
1.064
-
-
Volatility
0.35%, 0.77%
Prev Close
2.75%
Price
13.1
Change
5.22%
M12.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.88 | 4.41 | 8.59 | 16.93 | 15.58 | |
Net income per share | 0.39 | 0.56 | 0.37 | 0.48 | 0.24 | |
Operating cash flow per share | 0.17 | -0.2 | 0.5 | 0.84 | 1.15 | |
Free cash flow per share | 0.05 | -0.28 | 0.43 | 0.77 | 1.05 | |
Cash per share | 1.51 | 1.21 | 1.67 | 2.64 | 2.59 | |
Book value per share | 3.79 | 3.9 | 4.61 | 5.11 | 5.11 | |
Tangible book value per share | 3.3 | 2.96 | 2.29 | 2.43 | 2.65 | |
Share holders equity per share | 3.79 | 3.9 | 4.61 | 5.11 | 5.11 | |
Interest debt per share | -0.02 | 0.15 | 1.68 | 1.28 | 0.56 | |
Market cap | 248.82M | 242.38M | 166.14M | 134.89M | 163M | |
Enterprise value | 223.59M | 244.67M | 183.5M | 127.96M | 147.53M | |
P/E ratio | 37.63 | 24.91 | 24.35 | 15.15 | 37.76 | |
Price to sales ratio | 3.82 | 3.14 | 1.04 | 0.43 | 0.57 | |
POCF ratio | 86.97 | -68.77 | 17.71 | 8.61 | 7.75 | |
PFCF ratio | 325.47 | -49.77 | 20.94 | 9.42 | 8.47 | |
P/B Ratio | 3.9 | 3.55 | 1.94 | 1.42 | 1.74 | |
PTB ratio | 3.9 | 3.55 | 1.94 | 1.42 | 1.74 | |
EV to sales | 3.43 | 3.17 | 1.15 | 0.41 | 0.52 | |
Enterprise value over EBITDA | 31.47 | 21.82 | 21.38 | 7.4 | 10.12 | |
EV to operating cash flow | 78.15 | -69.42 | 19.56 | 8.17 | 7.02 | |
EV to free cash flow | 292.46 | -50.24 | 23.13 | 8.93 | 7.66 | |
Earnings yield | 0.03 | 0.04 | 0.04 | 0.07 | 0.03 | |
Free cash flow yield | 0 | -0.02 | 0.05 | 0.11 | 0.12 | |
Debt to equity | -0.01 | 0.03 | 0.36 | 0.24 | 0.1 | |
Debt to assets | -0.01 | 0.02 | 0.16 | 0.12 | 0.05 | |
Net debt to EBITDA | -3.55 | 0.2 | 2.02 | -0.4 | -1.06 | |
Current ratio | 7.89 | 4.11 | 2.11 | 2.54 | 2.86 | |
Interest coverage | 73.6 | 22.82 | 5.68 | 12.72 | 10.52 | |
Income quality | 0.43 | -0.36 | 1.37 | 1.76 | 4.87 | |
Dividend Yield | 0.02 | 0.02 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.75 | 0.54 | 0.02 | 0.19 | 0.42 | |
Sales general and administrative to revenue | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.12 | 0.18 | 0.39 | 0.48 | 0.48 | |
Capex to operating cash flow | -0.73 | 0.38 | -0.15 | -0.09 | -0.08 | |
Capex to revenue | -0.03 | -0.02 | -0.01 | 0 | -0.01 | |
Capex to depreciation | -2.95 | -0.4 | -0.32 | -0.24 | -0.3 | |
Stock based compensation to revenue | 0 | 0 | -0.07 | -0.01 | -0.03 | |
Graham number | 5.79 | 6.98 | 6.17 | 7.43 | 5.21 | |
ROIC | 0.08 | 0.07 | 0.02 | 0.07 | 0.05 | |
Return on tangible assets | 0.11 | 0.13 | 0.06 | 0.09 | 0.04 | |
Graham Net | 1.95 | 1.4 | 0.69 | 1.29 | 1.51 | |
Working capital | 38.97M | 44.89M | 64.34M | 66.78M | 69.84M | |
Tangible asset value | 55.46M | 51.74M | 42.63M | 45.18M | 48.48M | |
Net current asset value | 38.82M | 34.72M | 48.98M | 51.99M | 53.33M | |
Invested capital | -0.01 | 0.03 | 0.36 | 0.24 | 0.1 | |
Average receivables | 12.96M | 26.54M | 40.86M | 32.96M | 23.88M | |
Average payables | 874.1K | 4.34M | 11.81M | 14.34M | 16.03M | |
Average inventory | 1.41M | 1.46M | 21.92M | 38.76M | 31.39M | |
Days sales outstanding | 93.69 | 171.76 | 103.79 | 23.82 | 34.84 | |
Days payables outstanding | 6.41 | 44.55 | 39.61 | 16.25 | 26.62 | |
Days of inventory on hand | 9.91 | 8.71 | 105.83 | 44.53 | 38.2 | |
Receivables turnover | 3.9 | 2.13 | 3.52 | 15.32 | 10.48 | |
Payables turnover | 56.96 | 8.19 | 9.22 | 22.46 | 13.71 | |
Inventory turnover | 36.82 | 41.93 | 3.45 | 8.2 | 9.55 | |
ROE | 0.1 | 0.14 | 0.08 | 0.09 | 0.05 | |
Capex per share | -0.12 | -0.08 | -0.08 | -0.07 | -0.1 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.87 | 8.06 | 7.46 | 8.01 | 8.27 | |
Net income per share | 0.18 | 0.3 | 0.07 | 0.16 | 0.19 | |
Operating cash flow per share | 0.21 | 0.63 | 0.55 | 0.59 | 0.13 | |
Free cash flow per share | 0.18 | 0.59 | 0.51 | 0.54 | 0.1 | |
Cash per share | 3.11 | 2.64 | 2.79 | 2.59 | 2.69 | |
Book value per share | 4.91 | 5.11 | 5.19 | 5.11 | 5.38 | |
Tangible book value per share | 3.44 | 2.43 | 1.19 | 2.65 | 4.72 | |
Share holders equity per share | 4.91 | 5.11 | 5.19 | 5.11 | 5.38 | |
Interest debt per share | 0.47 | 1.25 | 0.65 | 0.54 | 0.4 | |
Market cap | 198.8M | 134.89M | 97.73M | 163M | 145.86M | |
Enterprise value | 185.75M | 127.96M | 90.88M | 147.53M | 138.17M | |
P/E ratio | 14.57 | 6.14 | 17.72 | 13.87 | 10.67 | |
Price to sales ratio | 1.21 | 0.9 | 0.7 | 1.11 | 0.97 | |
POCF ratio | 50.15 | 11.54 | 9.51 | 15.17 | 60.48 | |
PFCF ratio | 60.57 | 12.22 | 10.37 | 16.59 | 78.11 | |
P/B Ratio | 2.18 | 1.42 | 1.01 | 1.74 | 1.49 | |
PTB ratio | 2.18 | 1.42 | 1.01 | 1.74 | 1.49 | |
EV to sales | 1.13 | 0.85 | 0.66 | 1.01 | 0.92 | |
Enterprise value over EBITDA | 18.83 | 16.08 | 12.35 | 18.33 | 13.89 | |
EV to operating cash flow | 46.85 | 10.94 | 8.84 | 13.73 | 57.29 | |
EV to free cash flow | 56.59 | 11.59 | 9.64 | 15.02 | 74 | |
Earnings yield | 0.02 | 0.04 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.08 | 0.1 | 0.06 | 0.01 | |
Debt to equity | 0.09 | 0.24 | 0.12 | 0.1 | 0.07 | |
Debt to assets | 0.04 | 0.12 | 0.06 | 0.05 | 0.03 | |
Net debt to EBITDA | -1.32 | -0.87 | -0.93 | -1.92 | -0.77 | |
Current ratio | 2.94 | 2.54 | 3.05 | 2.86 | 2.73 | |
Interest coverage | 14.61 | 11.71 | 12.62 | 10.3 | 14.11 | |
Income quality | 1.16 | 2.13 | 7.46 | 3.66 | 0.71 | |
Dividend Yield | 0 | 0.01 | 0 | 0.01 | 0 | |
Payout ratio | 0 | 0.3 | 0 | 0.62 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.37 | 0.48 | 0.32 | 0.48 | 0.3 | |
Capex to operating cash flow | -0.17 | -0.06 | -0.08 | -0.09 | -0.23 | |
Capex to revenue | 0 | 0 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.24 | -0.23 | -0.3 | -0.29 | -0.2 | |
Stock based compensation to revenue | 0 | -0.05 | 0 | -0.05 | 0 | |
Graham number | 4.51 | 5.83 | 2.94 | 4.3 | 4.76 | |
ROIC | 0.04 | 0.03 | 0.02 | 0.03 | 0.04 | |
Return on tangible assets | 0.03 | 0.05 | 0.01 | 0.03 | 0.02 | |
Graham Net | 2.29 | 1.29 | 1.91 | 1.51 | 1.78 | |
Working capital | 85.89M | 66.78M | 69.21M | 69.84M | 73.1M | |
Tangible asset value | 63.98M | 45.18M | 82.4M | 48.48M | 86.12M | |
Net current asset value | 70.62M | 51.99M | 55.63M | 53.33M | 58.41M | |
Invested capital | 0.09 | 0.24 | 0.12 | 0.1 | 0.07 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 19.89 | 12.34 | 15.72 | 16.72 | 21.33 | |
Days payables outstanding | 9.45 | 8.47 | 10.42 | 12.87 | 15.69 | |
Days of inventory on hand | 20.23 | 23.2 | 18.31 | 18.47 | 17.54 | |
Receivables turnover | 4.52 | 7.29 | 5.72 | 5.38 | 4.22 | |
Payables turnover | 9.52 | 10.63 | 8.64 | 6.99 | 5.74 | |
Inventory turnover | 4.45 | 3.88 | 4.91 | 4.87 | 5.13 | |
ROE | 0.04 | 0.06 | 0.01 | 0.03 | 0.03 | |
Capex per share | -0.04 | -0.04 | -0.05 | -0.05 | -0.03 |
M12.DE Frequently Asked Questions
What is M1 Kliniken AG stock symbol ?
M1 Kliniken AG is a DE stock and trading under the symbol M12.DE
What is M1 Kliniken AG stock quote today ?
M1 Kliniken AG stock price is $13.1 today.
Is M1 Kliniken AG stock public?
Yes, M1 Kliniken AG is a publicly traded company.